Literature DB >> 16968623

Long-term treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD).

Lily Hechtman1.   

Abstract

Only 7% to 50% of children with attention-deficit/hyperactivity disorder actually are treated. Of those who begin treatment, only 18% to 50% persist in the treatment for any length of time (eg, 2 to 3 years). Thus, available data on effects of long-term medication and psychosocial treatment are sparse and problematic. This article reviews available data on long-term effects of medication (stimulant and nonstimulant) and psychosocial treatment.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16968623     DOI： 10.1007/s11920-006-0043-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   8.081


  63 in total

1.  Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD.

Authors:  Mariellen Fischer; Russell A Barkley; Lori Smallish; Kenneth Fletcher
Journal:  J Abnorm Child Psychol       Date:  2002-10

2.  Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children.

Authors:  D J Safer; R P Allen
Journal:  Pediatrics       Date:  1973-04       Impact factor: 7.124

3.  Anticipating the response to amphetamine therapy in the treatment of hyperkinetic children.

Authors:  W G Corad; J Insel
Journal:  Pediatrics       Date:  1967-07       Impact factor: 7.124

4.  Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

Authors:  J Biederman; T Wilens; E Mick; T Spencer; S V Faraone
Journal:  Pediatrics       Date:  1999-08       Impact factor: 7.124

Review 5.  Atomoxetine: the first nonstimulant for the management of attention-deficit/hyperactivity disorder.

Authors:  Shelby L Corman; Bethany A Fedutes; Colieen M Culley
Journal:  Am J Health Syst Pharm       Date:  2004-11-15       Impact factor: 2.637

6.  Which aspects of ADHD are associated with tobacco use in early adolescence?

Authors:  J D Burke; R Loeber; B B Lahey
Journal:  J Child Psychol Psychiatry       Date:  2001-05       Impact factor: 8.982

7.  The adolescent outcome of hyperactive children: predictors of psychiatric, academic, social, and emotional adjustment.

Authors:  M Fischer; R A Barkley; K E Fletcher; L Smallish
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1993-03       Impact factor: 8.829

8.  Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.

Authors:  Howard Abikoff; Lily Hechtman; Rachel G Klein; Richard Gallagher; Karen Fleiss; Joy Etcovitch; Lorne Cousins; Brian Greenfield; Diane Martin; Simcha Pollack
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-07       Impact factor: 8.829

9.  Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: impact on parental practices.

Authors:  Lily Hechtman; Howard Abikoff; Rachel G Klein; Brian Greenfield; Joy Etcovitch; Lorne Cousins; Karen Fleiss; Margaret Weiss; Simcha Pollack
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-07       Impact factor: 8.829

10.  Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.

Authors:  Timothy E Wilens; Stephen V Faraone; Joseph Biederman; Samantha Gunawardene
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124
View more
  5 in total

1.  Documenting adherence to psychostimulants in children with ADHD.

Authors:  Alice Charach; Amy Gajaria; Anna Skyba; Shirley Chen
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2008-08

2.  Methylphenidate administration to juvenile rats alters brain areas involved in cognition, motivated behaviors, appetite, and stress.

Authors:  Jason D Gray; Michael Punsoni; Nora E Tabori; Jay T Melton; Victoria Fanslow; Mary J Ward; Bojana Zupan; David Menzer; Jackson Rice; Carrie T Drake; Russell D Romeo; Wayne G Brake; Annelyn Torres-Reveron; Teresa A Milner
Journal:  J Neurosci       Date:  2007-07-04       Impact factor: 6.167

Review 3.  Pharmacologic treatment of ADHD: road conditions in driving patients to successful outcomes.

Authors:  Michael J Manos
Journal:  Medscape J Med       Date:  2008-01-08

4.  Medical and Psychiatric Comorbidities in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.

Authors:  Kee Jeong Park; Jung Sun Lee; Hyo-Won Kim
Journal:  Psychiatry Investig       Date:  2017-11-07       Impact factor: 2.505

5.  Protocol for the STAR (Sheffield Treatments for ADHD) project: an internal pilot study assessing the feasibility of the Trials within Cohorts (TwiCs) design to test the effectiveness of interventions for children with ADHD.

Authors:  Philippa Fibert; Clare Relton; Tessa Peasgood; David Daley
Journal:  Pilot Feasibility Stud       Date:  2018-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.